DR. RUPALI BARNWAL

Dr. MEHUL SHAH, Dr. SHREYA SHAH, DR. RAUNAQ KHANNA

Abstract

INTRODUCTION: BRVO IS A CAUSE OF BLINDNESS WOULD LIKE TO DO COMPARATIVE STUDY OF ANTI VEGF AND TRIAMCILONE VISUAL OUTCOME

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. CREATION OF FORMAT AND RETRIVAL OF DATA FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TRBULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: COHORT CONSISTED 155 EYES OF 152 PATIENTS 53.3%,46.7% M:F,MEAN AGE 57.4 YEARS,ON PRESENTATION 33.7 % HAD VISION >6/24 AND 41.1 % HAD VISION < 3/60 . POST TREATMENT VISION ON SUBSEQUENT VISITS>6/24 IN 32.5% AND <3/60 IN 21.8% CASES.WHEN WE COMPARED VISUAL OUTCOME AMONGST ANTI VEGF AND TRIMCINOLONE GROUP WE DID FIND SIGNIFICANT DIFFERENCE. (P=0.02) CONCLUSION: WE OBSERVED ANTI VEGF HAS SIGNIFICANTLY BETTER OUTCOME THAN TRIEMCINOLON ON VISUAL OUTCOME FOLLOWING MANAGEMENT OF BRVO [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP2062.pptx" width="100%" height="608"]